Ixico appoints Grant Nash as next CFO
Data analytics firm Ixico has appointed UK Biobank finance director Grant Nash as its new chief financial officer.
FTSE AIM All-Share
753.24
13:50 23/04/24
Ixico
8.76p
08:59 23/04/24
Pharmaceuticals & Biotechnology
21,835.24
13:50 23/04/24
During his time with Biobank, Nash, who will replace Ixico's interim head of finance Conor Woolfson, was responsible for the UK Biocentre, which provides biomedical sample processing and archiving logistics to large-scale research studies.
He was also involved in several fundraisings to raise up more than £140m for a variety of research and development projects
Chief executive Giulio Cerroni said: "I am delighted to welcome Grant to the company and I look forward to him bringing his financial leadership skills and experience in the sector to Ixico."
"We are at an exciting stage of the company's development, and Grant's business experience in international commercial and large-scale research and development organisations will assist the board and management team in delivering against our strategic objectives."
Woolfson will return to his role of group finance controller following Nash's appointment on 29 April.
As of 0820 GMT, Ixico shares were untraded at 35p.